NIH announced on Monday it will provide $70 million over five years to three collaborations searching for an HIV/AIDS cure, making it "the largest single investment yet ... into finding a way to rid the virus from the body or at least reduce levels to the point that infected people can stop taking anti-HIV drugs -- which many researchers until recently viewed as a hopeless quest," ScienceInsider reports (Cohen, 7/11).
The three grant recipients include teams from the University of North Carolina, Chapel Hill, and Merck Research Laboratories; the Fred Hutchinson Cancer Research Center and Sangamo Biosciences Inc.; and the University of California, San Francisco, working with the Vaccine & Gene Therapy Institute of Florida, according to an NIH press release (7/11).
Back to other news for July 2011
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.